FI974640A - Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit - Google Patents
Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit Download PDFInfo
- Publication number
- FI974640A FI974640A FI974640A FI974640A FI974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A
- Authority
- FI
- Finland
- Prior art keywords
- isochromanes
- migraine
- disubstituted
- treatment
- disubstituted isochromanes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74195P | 1995-06-30 | 1995-06-30 | |
US1123496P | 1996-02-06 | 1996-02-06 | |
PCT/US1996/008681 WO1997002259A1 (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Publications (2)
Publication Number | Publication Date |
---|---|
FI974640A0 FI974640A0 (fi) | 1997-12-30 |
FI974640A true FI974640A (fi) | 1997-12-30 |
Family
ID=26668092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI974640A FI974640A (fi) | 1995-06-30 | 1997-12-30 | Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0836599A1 (ja) |
JP (1) | JPH11509532A (ja) |
AU (1) | AU6252296A (ja) |
BR (1) | BR9609631A (ja) |
CA (1) | CA2225282A1 (ja) |
CZ (1) | CZ418597A3 (ja) |
FI (1) | FI974640A (ja) |
MX (1) | MX9710260A (ja) |
NO (1) | NO976112L (ja) |
PL (1) | PL324319A1 (ja) |
SK (1) | SK164297A3 (ja) |
WO (1) | WO1997002259A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
KR100823805B1 (ko) | 2004-05-05 | 2008-04-21 | 에프. 호프만-라 로슈 아게 | 5-ht6 수용체, 5-ht2a 수용체 또는 둘다를 조절하기에유용한 아릴설포닐 벤조다이옥산 |
CN101111472A (zh) | 2004-12-21 | 2008-01-23 | 弗·哈夫曼-拉罗切有限公司 | 1,2,3,4-四氢化萘和茚满衍生物及其作为5-ht拮抗剂的用途 |
DK1831159T3 (da) | 2004-12-21 | 2010-03-22 | Hoffmann La Roche | Tetralin og indanderivater samt anvendelser deraf |
KR100965190B1 (ko) | 2004-12-21 | 2010-06-24 | 에프. 호프만-라 로슈 아게 | 크로만 유도체 및 중추 신경계 장애의 치료에서 그의 용도 |
WO2006066745A1 (en) | 2004-12-21 | 2006-06-29 | F.Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
KR20070088798A (ko) | 2004-12-21 | 2007-08-29 | 에프. 호프만-라 로슈 아게 | 크로만 유도체 및 그의 5-ht 수용체 리간드로서의 용도 |
BRPI0618206A2 (pt) | 2005-11-03 | 2011-08-23 | Hoffmann La Roche | arilsulfonil cromanos como inibidores de 5-ht6, bem como composição farmacêutica, uso e processo para produção dos mesmos |
AU2007263084A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
EP2076489A1 (en) | 2006-06-20 | 2009-07-08 | F. Hoffmann-Roche AG | Arylsulfonamidyl tetralin derivatives and uses thereof |
CA2654822A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonyl naphthalene derivatives and uses thereof |
KR20110125258A (ko) * | 2009-03-05 | 2011-11-18 | 스미또모 가가꾸 가부시끼가이샤 | 할로겐 치환 벤젠디메탄올의 제조 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
AU684874B2 (en) * | 1993-12-28 | 1998-01-08 | Pharmacia & Upjohn Company | Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
-
1996
- 1996-06-07 EP EP96921264A patent/EP0836599A1/en not_active Withdrawn
- 1996-06-07 PL PL96324319A patent/PL324319A1/xx unknown
- 1996-06-07 JP JP9505135A patent/JPH11509532A/ja active Pending
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/cs unknown
- 1996-06-07 CA CA002225282A patent/CA2225282A1/en not_active Abandoned
- 1996-06-07 SK SK1642-97A patent/SK164297A3/sk unknown
- 1996-06-07 BR BR9609631A patent/BR9609631A/pt not_active Application Discontinuation
- 1996-06-07 MX MX9710260A patent/MX9710260A/es unknown
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/en not_active Application Discontinuation
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/no unknown
- 1997-12-30 FI FI974640A patent/FI974640A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
SK164297A3 (en) | 1998-09-09 |
FI974640A0 (fi) | 1997-12-30 |
NO976112L (no) | 1998-03-02 |
CZ418597A3 (cs) | 1998-06-17 |
MX9710260A (es) | 1998-03-29 |
NO976112D0 (no) | 1997-12-29 |
JPH11509532A (ja) | 1999-08-24 |
AU6252296A (en) | 1997-02-05 |
EP0836599A1 (en) | 1998-04-22 |
WO1997002259A1 (en) | 1997-01-23 |
BR9609631A (pt) | 1999-03-02 |
CA2225282A1 (en) | 1997-01-23 |
PL324319A1 (en) | 1998-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO981800D0 (no) | FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan | |
NO961483D0 (no) | Fremgangsmåte for behandling av oljeholdig formasjon | |
FI974640A (fi) | Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit | |
ITTO940748A0 (it) | Condotto protesico particolarmente per il trattamento di patologie cardiovascolari. | |
HUP0004085A3 (en) | Novel 3,6-hemiketals from the class of 9a-azalides | |
BR9609884A (pt) | N-aril- 1,2,4-triazolin-5-onas | |
ITTO960495A0 (it) | Procedimento per accrescere il flusso per elettrotrasporto di polipep-tidi. | |
DE69618634D1 (de) | 1,4-benzodioxin-derivate | |
IT1292552B1 (it) | Dispositivo per l'applicazione di rivestimenti. | |
DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
NO985535D0 (no) | FremgangsmÕte for fremstilling av 1,3-alkandioler | |
ATE220674T1 (de) | 12h-dibenzo(d,g)(1,3)dioxocin derivate | |
HK1010095A1 (en) | Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals. | |
ID16434A (id) | Senyawa-senyawa 1,4-dihidropiridin | |
DK0783491T3 (da) | Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid | |
ES1031096Y (es) | Ducha antivandalica. | |
EP0579077A3 (en) | 1,3,4-thiadiazinones for the treatment of cardiovascular diseases | |
FI940088A0 (fi) | Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett | |
DK0737068T3 (da) | 2,3-diaryl-1-benzopyraner til behandling af dermatitis | |
RU95117268A (ru) | Средство для лечения атопического дерматита | |
BR9610047A (pt) | 1,3,4-oxadiazolin-2-onas | |
FI953860A0 (fi) | Yhdistelmäpalkki | |
ITRM940468A0 (it) | "impiego di esteruretani per ls riconcia". | |
ITTV940061A0 (it) | "pedana, particolarmente per la pratica della scherma". | |
FI954263A0 (fi) | Vid skjutning anvaendbart foerfarande foer bestaemning av traeffar |